Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;37(6):1635-1641.
doi: 10.1111/jocs.16408. Epub 2022 Mar 15.

Transapical-transcatheter aortic valve implantation in patients without transvascular options: Modified transapical approach

Dritan Useini  1 , Markus Schlömicher  1 , Peter Haldenwang  1 , Dirk Buchwald  1 , Justus Strauch  1
Affiliations

Transapical-transcatheter aortic valve implantation in patients without transvascular options: Modified transapical approach

Dritan Useini et al. J Card Surg. 2022 Jun.

Abstract

Objectives: Outcomes in patients with iliofemoral and concomitant iliofemoral-remote arteriopathies who cannot undergo transfemoral or other alternative transvascular approaches have not been studied so far. This study aimed to evaluate the early and midterm outcomes after transapical (TA)-transcatheter aortic valve implantation (TAVI) in patients with femoral and femoral-remote arteriopathies who cannot undergo transvascular approaches.

Methods: Multimorbid patients with severe aortic stenosis and distinct panarteriopathy underwent TA-TAVI treatment between January 2012 and January 2021 at the authors' institution. Second- and third-generation self- and balloon-expanding valves were used. For patients without arterial access, TA-TAVI was modified to the artery-no-touch technique.

Results: Seventy-two consecutive elderly patients (78.2 ± 6.9 years; 73% male) were included in the study. The Society of Thoracic Surgery-Predicted Risk of Mortality score was 7 ± 5%. No procedural deaths or conversion to conventional surgery was registered. The 30-day and midterm mortality rates were 5% and 28%, respectively. The median time of freedom from a composite of death and cardiocerebral adverse events was 34.3 months (95% confidence interval: 17.6-51.1). The rate of moderate/severe paravalvular leakage was 0%. The pacemaker rate was 11%.

Conclusions: TA-TAVI is a safe method with low-rate procedural complications and shows good early and midterm outcomes in patients with extensive panarteriopathy for whom transfemoral and other alternative transvascular approaches are contraindicated or at high interventional risk. The modified artery-no-touch TA-TAVI method is safe and feasible for selected patients with no other possible arterial approach.

Keywords: outcome; peripheral arterial diseases; transcatheter aortic valve implantation.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Vemulapalli S, Carroll JD, Mack MJ, et al. Procedural volume and outcomes for transcatheter aortic-valve replacement. N Engl J Med. 2019;380(26):2541-2550.
    1. Kindzelski B, Mick SL, Krishnaswamy A, et al. Evolution of Alternative access transcatheter aortic valve replacement. Ann Thorac Surg. 2021;112(6):1877-1885.
    1. Debry N, Trimech TR, Gandet T, et al. Transaxillary compared with transcarotid access for TAVR: a propensity-matched comparison from a French multicentre registry. EuroIntervention. 2020;16(10):842-849.
    1. Allen KB, Chhatriwalla AK, Saxon J, et al. Transcarotid versus transthoracic access for transcatheter aortic valve replacement: a propensity-matched analysis. J Thorac Cardiovasc Surg. 2020;S0022-5223(20):32831-32832.
    1. Marie B, David CH, Guimbretière G, et al. Carotid versus femoral access for transcatheter aortic valve replacement: comparable results in the current era. Eur J Cardiothorac Surg. 2021;60(4):874-879.

LinkOut - more resources